Ardelyx (NASDAQ: ARDX) revenue
Ardelyx reported revenue of $407.3m for fiscal 2025, 22.1% more than in fiscal 2024 ($333.6m). Since fiscal 2017 its revenue has grown by 869.8%, an average growth of 32.8% a year.
Ardelyx has grown its revenue for 7 years in a row, and fiscal 2025 is the highest of its 9 fiscal years on record. The biggest drop was in fiscal 2018, −93.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $407.3m | +22.1% | −$41.0m | −10.1% |
| 2024 | $333.6m | +168.1% | −$28.0m | −8.4% |
| 2023 | $124.5m | +138.6% | −$63.3m | −50.8% |
| 2022 | $52.2m | +416.6% | −$63.8m | −122.2% |
| 2021 | $10.1m | +33.4% | −$154.3m | −1,528.6% |
| 2020 | $7.6m | +43.4% | −$90.8m | −1,199.0% |
| 2019 | $5.3m | +102.6% | −$91.3m | −1,728.1% |
| 2018 | $2.6m | −93.8% | −$90.9m | −3,488.6% |
| 2017 | $42.0m | — | −$65.1m | −155.0% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Ardelyx revenue compared with its sector
By revenue for its latest fiscal year, Ardelyx ranks 204th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Ardelyx, 22.1%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 202nd | MiMedx Group | $418.6m | 20.0% |
| 203rd | Innoviva | $411.3m | 14.7% |
| 204th | Ardelyx | $407.3m | 22.1% |
| 205th | Immunocore | $400.0m | 29.0% |
| 206th | Krystal Biotech | $389.1m | 33.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Ardelyx
- How much revenue did Ardelyx make in fiscal 2025?
- Ardelyx reported revenue of $407.3m for fiscal 2025, compared with $333.6m in fiscal 2024.
- How much has the revenue of Ardelyx grown?
- Between fiscal 2017 and fiscal 2025 it went from $42.0m to $407.3m: 869.8% more, an average growth of 32.8% a year.
- What was the best year for revenue at Ardelyx?
- Of its last 9 fiscal years, fiscal 2025, with $407.3m.
- Where does Ardelyx rank in its sector by revenue?
- It ranks 204th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Ardelyx come from?
- From the annual report (Form 10-K) that Ardelyx files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Ardelyx files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Ardelyx: the Ardelyx page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.